The hematopoietic cell transplantation comorbidity index is a predictor of early death and survival in adult acute myeloid leukemia patients
Authors:
- Aleksandar SavicASAleksandar Savic
- Vanja KvrgicVKVanja Kvrgic
- Nebojsa RajicNRNebojsa Rajic
- Ivana UrosevicIUIvana Urosevic
- Dragan KovacevicDKDragan Kovacevic
- Ivanka PercicIPIvanka Percic
- Stevan PopovicSPStevan Popovic
- 1 April 2012
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 36 (4) , 479-482
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Acute Myeloid LeukemiaJournal of the National Comprehensive Cancer Network, 2011
- Comorbidity as a risk factor for overall survival and decision criteria for intensity of chemotherapy in elderly patients with acute myeloid leukemiaMedical Oncology, 2011
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNetBlood, 2010
- Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia RegistryBlood, 2009
- Outcome of hyperleukocytic adult acute myeloid leukaemia: A single-center retrospective study and review of literatureLeukemia Research, 2008
- The haematopoietic cell transplantation comorbidity index score is predictive of early death and survival in patients over 60 years of age receiving induction therapy for acute myeloid leukaemia.British Journal of Haematology, 2007
- Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCTBlood, 2005
- Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative GroupBritish Journal of Haematology, 1976